Daejeon, South Korea

Song Kyu Park

USPTO Granted Patents = 4 


Average Co-Inventor Count = 13.6

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • Taejeon-si, KR (2012)
  • Daejeon, KR (2010 - 2015)

Company Filing History:


Years Active: 2010-2015

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Song Kyu Park - Pioneering Cancer Treatments and PPase Inhibitors

Introduction:

Song Kyu Park, a renowned inventor hailing from Daejeon, South Korea, has made significant contributions to the fields of oncology and pharmaceuticals. With a total of four patents to his name, Park's innovative research focuses on developing compounds with HIF-1 inhibition activity and rhodanine derivatives that show promise in cancer treatment and PPase-caused diseases.

Latest Patents:

Among his latest patents, Song Kyu Park has successfully developed an Aryloxy phenoxy acrylic compound that exhibits remarkable HIF-1 inhibition activity. This compound has shown efficacy in combating various solid tumors such as colon cancer, liver cancer, stomach cancer, and breast cancer by targeting the important transcription factor, HIF-1. Additionally, the patent highlights the potential use of the compound in treating diabetic retinopathy and arthritis.

Park's innovation also extends to the discovery of rhodanine derivatives with inhibitory activity against protein phosphatases (PPase), including PTP1B, Prl-3, LAR, and others. These derivatives hold promise for the prevention and treatment of PPase-related diseases such as autoimmune conditions, diabetes, obesity, and certain cancers.

Career Highlights:

Song Kyu Park's expertise and passion for innovation have led him to collaborate with esteemed institutions such as the Korea Research Institute of Bioscience and Biotechnology and the Dongguk University Industry-Academic Cooperation Foundation. Through his work in these organizations, Park has been able to further his research and bring groundbreaking discoveries to light.

Collaborations:

Throughout his career, Song Kyu Park has had the privilege of working with notable colleagues in the field, including Hwan Mook Kim and Chang Woo Lee. These collaborations have not only enriched his research endeavors but have also fostered a culture of innovation and excellence in the scientific community.

Conclusion:

In conclusion, Song Kyu Park's inventive spirit and dedication to advancing cancer treatments and pharmaceutical solutions have solidified his reputation as a pioneering inventor in the industry. His groundbreaking patents and collaborative efforts underscore his commitment to driving meaningful change and improving healthcare outcomes for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…